Skip to main content
. 2021 Apr 27;36(7):1507–1513. doi: 10.1007/s00384-021-03933-7

Table 1.

Baseline characteristics of patients with and without elevated inflammatory markers

Variable Total (n = 1303) Patients without elevated inflammatory markers (n = 23) Patients with elevated inflammatory markers (n = 1280) p Value

Age, median (IQR) in years

Missing n = 0

39 (27-54) 31 (27-51) 39 (27-54) 0.31

Sex, male (%)

Missing n = 0

652 (50.0) 9 (39.1) 643 (50.2) 0.29

ASA (%)

Missing n = 0

I–II 1254 (96.2) 22 (95.7) 1332 (96.3 0.59*
III–IV 49 (3.8) 1 (4.3) 48 (3.8)

Duration of symptoms < 2 or > 2 days (%)

Missing n = 30

< 2 days 1032 (79.2) 16 (69.6) 1016 (79.4) 0.18*
> 2 days 241 (18.5) 7 (30.4) 234 (18.3)

Migration of pain (%)

Missing n = 38

555 (42.6) 4 (17.4) 551 (43.0) 0.01*

Nausea (%)

Missing n = 31

888 (68.2) 15 (65.2) 873 (68.2) 0.63

Vomiting (%)

Missing n = 27

448 (34.4) 5 (21.7) 443 (34.6) 0.18

Fever, ≥ 38.5 ° Celsius (%)

Missing n = 72

238 (18.3) 1 (4.3) 237 (18.5) 0.10*

Peritonitis (%)

Missing n = 48

Localized 1129 (86.6) 18 (78.3) 1111 (86.8) 0.46*
Diffuse 126 (9.7) 3 (13.0) 123 (9.6)

Inflammatory

markers

Missing n = 0

WBC, mean (SD) 10˄9/L 13.9 (4.5) 8.5 (1.8) 14.0 (4.5) <0.001
CRP, median (IQR) mg/L 39 (13-86) 2 (1-4) 40 (15-87) <0.001

Time to surgery, median (IQR) in hours

Missing n = 22

7.1 (4.5-13.6) 7.1 (3.3-17.8) 7.1 (4.5-13.5) 0.82

Type of appendectomy ITT (%)

Missing n = 0

Laparoscopic 1029 (79.0) 15 (65.2) 1014 (19.2) 0.12*
Open 268 (20.6) 8 (34.8) 160 (20.3)

Duration of surgery, median (IQR) in min

Missing n = 55

42 (32–56) 34 (28–47) 43 (32–56) 0.08

LOS, median (IQR) in days

Missing n = 0

2 (1–4) 2 (1–3) 2 (1–4) 0.90

Abbreviations: ASA American Society of Anesthesiologists; IQR interquartile range, ITT intention to treat, LOS length of stay

*Fisher’s exact test was used